5Itokazu G S, Quinn J P, Bell-Dixon C, et al. Antimicroblal resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program [J]. Clin Infect Dis. 1996,23 : 779.
6Jarvis W R, Martone W J. Predominant pathogens in hospital infections [J]. J Antimicrob Chemother, 1992, 29 (Suppl A):19.
7Wekthagen G F. Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudornonas aeruginasa: novel developments and clinical impact [J]. Antimicrob Agents Chemother, 2003,47 (8) ; 2385.
8Poirel L, Weldhagen G F, Champs C D, et al. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamases GES-2 in South Africa [J]. J Antimicrob Chemother, 2002,49 : 561.
9Manikal V M, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage [J]. Clin Infect Dis,2000, 31:101.
10Yong D, Shin J H, Kim S, et al. High prevalence of PER1 extended-spectrum beta-lactamases in Acinetobacter spp. in Korea [J]. Antimicrob Agents Chemother ,2003,47 ( 5 ) : 1749.
二级参考文献48
1Tsakris A, Pournaras S, Woodford N, et al. Outbreak d infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol, 2000.38: 1290-1292.
2Poirel L, Naas T, Nicolas D, et al. Characterization d VIM-2, a carbapanem-hydrolyzing metallo-beta-lactamase and its plasmid-and integron-borne gene from a Psedomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000.44: 891-897.
3Yah J, Hsueh P, Ko W, et al. Metallo-beta-lactamase in clinical Psedumonas isolates in Taiwan and identification d VIM-3, a novel variant of VIM-2 enzyme. Antimicrob Agents Chemother, 2001,45 :2224-2228.
4Yum JH, Yi K, Lee H, et al. Molecular characterization of metallobeta-lactamase-producing Acinetobacter bsumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla (VIM-2) gene cassettes. J Antimicrob Chemother,2002, 49: 837-840.
5Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother, 2000, 44:1556-1561.
6Afzal-Shah M,Woodford N,Liermore DM,Characterization of OXA-25,OXA-26,and OXA-27,molecular class D bet-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.Antimicrob Agents Chemother,2001,45:583-588.
7Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect, 2002, 8: 321-331.
8Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol, 2000, 3:489-495.
9Bush K. Metallo-beta-lactamases: a class apart. Clin Infect Dis,1998, 27 Suppl 1 :S48-53.
10Rasmussen BA, Bush K. Carbapenem-hydrolyzing bots-Isctamases.Antimicrob Agents Chemother, 1997, 41:223-232.
